跳至主要内容
临床试验/NCT02235935
NCT02235935Unknown不适用

The Effect of Hyperbaric Chamber Treatment on Patients With Diabetic Retinopathy

Assaf-Harofeh Medical Center1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2014年9月最近更新:
适应症

试验速览

阶段
不适用
入组人数
40
试验地点
1
主要终点
OCT results

研究概览

简要总结

Diabetic retinopathy (DR) is a common complication of diabetes and is divided into non proliferative DR and proliferative DR. The damage is caused by either macular edema, macular ischemia that can be followed by vascular proliferation.

Hyperbaric chamber treatment assists in increasing the amount of oxygen in the plasma and in the tissues and has been proven to be beneficial in treating different wounds in diabetic patients but its effect hasn't been tested in diabetic retinopathy yet.

This study will recruit 40 diabetic patients who are scheduled for hyperbaric treatment due to different indications such as chronic wounds or radiation damages and who also have diabetic retinopathy. These patients will undergo opthalmic physical examination including fundus photography and OCT (Optical Coherence Tomography - optical IR retinal photography). Screening for these patients will be conducted at the Hyperbaric chamber at Assaf Harofe Medical Center for all diabetic patients prior to their first treatment.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Inclusion criteria:
  • Patients between ages 18-90 with Diabetes type I or II and diabetic retinopathy who are scheduled for hyperbaric treatment for other indications than DR.
  • Patients who signed an informed consent form and agree to undergo an ophthalmic physical examination, Fundus photography and OCT prior to hyperbaric treatment and oCT exam following every 10 treatments in hyperbaric chamber. Total number of hyperbaric treatments will be conducted according to the main indication for which they have been assigned this treatment.

排除标准

  • Patients with Carotid stenosis of more than 70%
  • Anemia of < 10mg/Dl
  • Patients with chest X ray pathology which cannot be admitted to hyperbaric chamber treatment.
  • Patients with claustrophobia or that cannot decompress properly.
  • Patients with any malignant disease
  • Patients with inability to sign informed consent
  • Decompression treatment will last 90 minutes in 2 atmospheres pressure with 100% oxygen.

结局指标

主要结局

OCT results

时间窗: 1 month

the reduction in retina width as recorded on OCT following 20 treatments in Hyperbaric Chamber

次要结局

  • Visual Acuity(1 month)

研究者

申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验